Skip to main content
NCBI home page
Mediators of Inflammation logoLink to Mediators of Inflammation
. 1993;2(4):293–297. doi: 10.1155/S0962935193000407

Anti-inflammatory agents and substance P depletion in experimental ileitis

M J S Miller 1,✉, H Sadowska-Krowicka 1, S Chotinaruemol 1, M Wong 2, D A Clark 1, A Y Jeng 2
PMCID: PMC2365414  PMID: 18475536

Abstract

To understand the interactions between substance P and gut inflammation, changes in substance P levels were evaluated in a chronic model of ileitis in response to three anti-inflammatory agents with distinct mechanisms of action. The agents were the prostaglandin E1 analogue misoprostol (30 μg/kg, s.c., b.i.d.), the nitric oxide synthase inhibitor NG-nitro-L-arginine methyl ester (L-NAME, 100 μg/ml in drinking water) and the leumedin, N-(fluorenyl-9-methoxycarbonyl)-L-leucine (NPC 15199, 10 mg/kg, s.c.). Ileitis was induced by a transmural injection of trinitrobenzene sulphonic acid (TNBS 30 mg/kg in 50% ethanol) into the distal ileum of guinea-pigs. All anti-inflammatory therapies were introduced after TNBS administration and continued until day 7, when guinea-pigs were killed. Ileal substance P levels were measured by radioimmunoassay, and granulocyte infiltration was quantified by myeloperoxidase (MPO) activity. Protein and nitrite (an index of nitric oxide formation) levels in a luminal saline lavage were quantified in all groups. TNBS ileitis caused a marked reduction in ileal substance P content and increased MPO activity, protein and nitrite secretion. The nitric oxide synthase inhibitor, L-NAME, completely restored all parameters to baseline. Misoprostol attenuated the granulocyte infiltration and exacerbated protein leak but had no effect on substance P levels. In contrast, NPC 15199 had no effect on granulocyte infiltration but normalized substance P levels and protein leak. Only L-NAME and NPC 15199 blocked the TNBS induced increase in nitrite levels. These results suggest that the regulation of granulocyte infiltration in this model is unrelated to changes in substance P levels. Inhibition of nitric oxide synthase was the most effective therapeutic strategy in TNBS ileitis but the precise interactions between nitric oxide and the enteric nervous system during inflammatory states remain to be defined.

Full Text

The Full Text of this article is available as a PDF (514.2 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Allgayer H., Deschryver K., Stenson W. F. Treatment with 16,16'-dimethyl prostaglandin E2 before and after induction of colitis with trinitrobenzenesulfonic acid in rats decreases inflammation. Gastroenterology. 1989 May;96(5 Pt 1):1290–1300. doi: 10.1016/s0016-5085(89)80016-2. [DOI] [PubMed] [Google Scholar]
  2. Bator J. M., Weitzberg M., Burch R. M. N-[9H-(2,7-dimethylfluorenyl-9-methoxy)carbonyl]-L-leucine, NPC 15669, prevents neutrophil adherence to endothelium and inhibits CD11b/CD18 upregulation. Immunopharmacology. 1992 Mar-Apr;23(2):139–149. doi: 10.1016/0162-3109(92)90038-e. [DOI] [PubMed] [Google Scholar]
  3. Borson D. B., Brokaw J. J., Sekizawa K., McDonald D. M., Nadel J. A. Neutral endopeptidase and neurogenic inflammation in rats with respiratory infections. J Appl Physiol (1985) 1989 Jun;66(6):2653–2658. doi: 10.1152/jappl.1989.66.6.2653. [DOI] [PubMed] [Google Scholar]
  4. Burch R. M., Weitzberg M., Blok N., Muhlhauser R., Martin D., Farmer S. G., Bator J. M., Connor J. R., Green M., Ko C. N-(fluorenyl-9-methoxycarbonyl) amino acids, a class of antiinflammatory agents with a different mechanism of action. Proc Natl Acad Sci U S A. 1991 Jan 15;88(2):355–359. doi: 10.1073/pnas.88.2.355. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Costa M., Cuello A. C., Furness J. B., Franco R. Distribution of enteric neurons showing immunoreactivity for substance P in the guinea-pig ileum. Neuroscience. 1980;5(2):323–331. doi: 10.1016/0306-4522(80)90108-6. [DOI] [PubMed] [Google Scholar]
  6. Grisham M. B., Ware K., Gilleland H. E., Jr, Gilleland L. B., Abell C. L., Yamada T. Neutrophil-mediated nitrosamine formation: role of nitric oxide in rats. Gastroenterology. 1992 Oct;103(4):1260–1266. doi: 10.1016/0016-5085(92)91513-4. [DOI] [PubMed] [Google Scholar]
  7. Ischiropoulos H., Zhu L., Beckman J. S. Peroxynitrite formation from macrophage-derived nitric oxide. Arch Biochem Biophys. 1992 Nov 1;298(2):446–451. doi: 10.1016/0003-9861(92)90433-w. [DOI] [PubMed] [Google Scholar]
  8. Jeng A. Y., Wong M., Lovato S. J., Erion M. D., Gilligan J. P. A radioimmunoassay for measuring alpha-amidating enzyme activity. Anal Biochem. 1990 Mar;185(2):213–219. doi: 10.1016/0003-2697(90)90282-e. [DOI] [PubMed] [Google Scholar]
  9. Koch T. R., Carney J. A., Go V. L. Distribution and quantitation of gut neuropeptides in normal intestine and inflammatory bowel diseases. Dig Dis Sci. 1987 Apr;32(4):369–376. doi: 10.1007/BF01296290. [DOI] [PubMed] [Google Scholar]
  10. Konttinen Y. T., Kemppinen P., Segerberg M., Sorsa T., Saari H., Hukkanen M. Reactive oxygen species induced structural alterations of substance P. Mediators Inflamm. 1992;1(5):355–360. doi: 10.1155/S096293519200053X. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Kubes P., Suzuki M., Granger D. N. Nitric oxide: an endogenous modulator of leukocyte adhesion. Proc Natl Acad Sci U S A. 1991 Jun 1;88(11):4651–4655. doi: 10.1073/pnas.88.11.4651. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Mantyh P. W., Catton M. D., Boehmer C. G., Welton M. L., Passaro E. P., Jr, Maggio J. E., Vigna S. R. Receptors for sensory neuropeptides in human inflammatory diseases: implications for the effector role of sensory neurons. Peptides. 1989 May-Jun;10(3):627–645. doi: 10.1016/0196-9781(89)90154-x. [DOI] [PubMed] [Google Scholar]
  13. Miller M. J., Sadowska-Krowicka H., Chotinaruemol S., Kakkis J. L., Clark D. A. Amelioration of chronic ileitis by nitric oxide synthase inhibition. J Pharmacol Exp Ther. 1993 Jan;264(1):11–16. [PubMed] [Google Scholar]
  14. Miller M. J., Zhang X. J., Gu X. A., Clark D. A. Acute intestinal injury induced by acetic acid and casein: prevention by intraluminal misoprostol. Gastroenterology. 1991 Jul;101(1):22–30. doi: 10.1016/0016-5085(91)90455-t. [DOI] [PubMed] [Google Scholar]
  15. Morris G. P., Beck P. L., Herridge M. S., Depew W. T., Szewczuk M. R., Wallace J. L. Hapten-induced model of chronic inflammation and ulceration in the rat colon. Gastroenterology. 1989 Mar;96(3):795–803. [PubMed] [Google Scholar]
  16. Nathan C. Nitric oxide as a secretory product of mammalian cells. FASEB J. 1992 Sep;6(12):3051–3064. [PubMed] [Google Scholar]
  17. Nichols K., Krantis A., Staines W. Histochemical localization of nitric oxide-synthesizing neurons and vascular sites in the guinea-pig intestine. Neuroscience. 1992 Dec;51(4):791–799. doi: 10.1016/0306-4522(92)90520-c. [DOI] [PubMed] [Google Scholar]
  18. Salter M., Knowles R. G., Moncada S. Widespread tissue distribution, species distribution and changes in activity of Ca(2+)-dependent and Ca(2+)-independent nitric oxide synthases. FEBS Lett. 1991 Oct 7;291(1):145–149. doi: 10.1016/0014-5793(91)81123-p. [DOI] [PubMed] [Google Scholar]
  19. Sharkey K. A. Substance P and calcitonin gene-related peptide (CGRP) in gastrointestinal inflammation. Ann N Y Acad Sci. 1992;664:425–442. doi: 10.1111/j.1749-6632.1992.tb39781.x. [DOI] [PubMed] [Google Scholar]
  20. Stead R. H., Bienenstock J., Stanisz A. M. Neuropeptide regulation of mucosal immunity. Immunol Rev. 1987 Dec;100:333–359. doi: 10.1111/j.1600-065x.1987.tb00538.x. [DOI] [PubMed] [Google Scholar]
  21. Yamada T., Fujimoto K., Tso P., Fujimoto T., Gaginella T. S., Grisham M. B. Misoprostol accelerates colonic mucosal repair in acetic acid-induced colitis. J Pharmacol Exp Ther. 1992 Jan;260(1):313–318. [PubMed] [Google Scholar]

Articles from Mediators of Inflammation are provided here courtesy of Wiley

RESOURCES